Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
- Weitere Titel
-
Prophylaxe von Infektionen durch das respiratorische Synzytialvirus bei Frühgeborenen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates ; volume:229 ; number:05 ; year:2017 ; pages:259-260
Klinische Pädiatrie ; 229, Heft 05 (2017), 259-260
- Beteiligte Personen und Organisationen
-
Gortner, Ludwig
- DOI
-
10.1055/s-0043-116334
- URN
-
urn:nbn:de:101:1-2018121907440964556518
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gortner, Ludwig
Ähnliche Objekte (12)
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
Non-invasive respiratory support for preterm neonates requiring resuscitation
Nephrocalcinosis in preterm neonates
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
The psychology of preterm neonates
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
Severe Respiratory Syncytial Virus Infection
Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
Exposure of neonates to Respiratory Syncytial Virus is critical in determining subsequent airway response in adults
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
Non-invasive respiratory support for preterm neonates requiring resuscitation
Nephrocalcinosis in preterm neonates
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
The psychology of preterm neonates
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
Severe Respiratory Syncytial Virus Infection
Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
Exposure of neonates to Respiratory Syncytial Virus is critical in determining subsequent airway response in adults
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
Non-invasive respiratory support for preterm neonates requiring resuscitation
Nephrocalcinosis in preterm neonates
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
The psychology of preterm neonates
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
Severe Respiratory Syncytial Virus Infection
Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants